Efficacy and Safety of Nefecon on Prevention of Relapse of IgA Nephropathy: a Randomized, Double-blinded, Placebo-Controlled Trial

by palligoelme@gmail.com | May 22, 2026 | Clinical Trials

​ Conditions: IgA Nephropathy (IgAN) Interventions: Drug: NEFECON; Drug: Placebo Sponsors: Nanfang Hospital, Southern Medical University Not yet recruiting Conditions: IgA Nephropathy (IgAN) Interventions: Drug: NEFECON; Drug: Placebo Sponsors: Nanfang Hospital,...

Transcranial Sonography and Machine Learning for Schizophrenia Identification

by palligoelme@gmail.com | May 22, 2026 | Clinical Trials

​ Conditions: Schizophrenia Interventions: Diagnostic Test: Transcranial Sonography Sponsors: Taizhou Second People’s Hospital Not yet recruiting Conditions: Schizophrenia Interventions: Diagnostic Test: Transcranial Sonography Sponsors: Taizhou Second...

Development and Validation of an E-learning Module on Systemic Anticancer Therapy and Its Effectiveness on the Knowledge Attitude and Practice of Nurses in Administering Systemic Anticancer Agents at a Specialized Cancer Centres in Oman.

by palligoelme@gmail.com | May 22, 2026 | Clinical Trials

​ Conditions: E-learning; Knowledge; Attitude; Practice Interventions: Other: E-Learning; Other: No E-Learning Sponsors: Sultan Qaboos Comprehensive Cancer Center Not yet recruiting Conditions: E-learning; Knowledge; Attitude; Practice Interventions: Other:...

The Feasibility and Acceptability of a Collaborative Deprescribing Intervention to Reduce Anticholinergic Burden Among Hospitalised Older Patients

by palligoelme@gmail.com | May 20, 2026 | Clinical Trials

​ Conditions: Eligible Patients Are Aged 65 Years or More Admitted to One of the Five Medicines for Older People Wards, Who Have ACB Score of 3 or More Interventions: Other: Patients will receive a collaborative deprescribing intervention Sponsors: University of...

MEVA Cognitive Wellness Platform Study for Adults

by palligoelme@gmail.com | May 20, 2026 | Clinical Trials

​ Conditions: Cognitive Wellness; Healthy Aging; Age-Related Cognitive Change; Aging; Cognitive Change; Health Behavior; Primary Care Interventions: Behavioral: MEVA Cognitive Wellness Platform Sponsors: Mentage LLC Not yet recruiting Conditions: Cognitive Wellness;...

Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema

by palligoelme@gmail.com | May 20, 2026 | Clinical Trials

​ Conditions: Diabetic Retinopathy Interventions: Drug: Surabgene Lomparvovec; Drug: Sham; Drug: Topical Steroid; Drug: Artificial Tears Sponsors: AbbVie Recruiting Conditions: Diabetic Retinopathy Interventions: Drug: Surabgene Lomparvovec; Drug: Sham; Drug: Topical...